Secondary Hypertension: Chronic Kidney Disease (CKD), Renovascular Disease, Primary Hyperaldosteronism, Cushing’s Syndrome, Pheochromocytoma, Obstructive Sleep Apnea (OSA), and Medication-Induced

A table summarizing the key points about Secondary Hypertension:

Cause	Mechanism	Diagnostic Tests	Management
Chronic Kidney Disease (CKD)	Impaired sodium excretion and RAAS activation	- Serum creatinine, BUN, urinalysis - Renal ultrasound - Plasma renin activity and aldosterone levels	- ACE inhibitors or ARBs - Dialysis or kidney transplant in advanced cases
Renovascular Disease	Renal artery stenosis causing RAAS activation	- Renal Doppler ultrasound - CT/MR angiography - Captopril renal scan	- Angioplasty or stenting - ACE inhibitors or ARBs (caution in bilateral stenosis)
Primary Hyperaldosteronism	Excess aldosterone causes sodium retention and hypokalemia	- PAC > 15-20 ng/dL - PRA < 1 ng/mL/hr - ARR > 20-30 - Confirmatory saline infusion or oral sodium loading test	- Adrenalectomy for adenomas - Spironolactone for bilateral adrenal hyperplasia
Cushing’s Syndrome	Excess cortisol enhances catecholamine sensitivity	- 24-hour urinary free cortisol - Low-dose dexamethasone suppression test - Serum ACTH, imaging (CT/MRI)	- Surgery (adrenalectomy or pituitary tumor removal) - Cortisol-lowering drugs if surgery is not feasible
Pheochromocytoma	Excess catecholamines (epinephrine, norepinephrine)	- Plasma free metanephrines or urinary fractionated metanephrines - Clonidine suppression test - Imaging (CT/MRI)	- Surgical tumor removal - Preoperative alpha-blockade (phenoxybenzamine), followed by beta-blockers
Obstructive Sleep Apnea (OSA)	Sympathetic activation during apneic episodes	- Polysomnography (sleep study)	- CPAP therapy - Weight loss - Antihypertensive therapy as adjunct
Medication-Induced Hypertension	Drug-induced sodium retention or vasoconstriction	- Medication history review (NSAIDs, decongestants, oral contraceptives, corticosteroids)	- Discontinuation or substitution of offending medication - Antihypertensive therapy as needed

This table summarizes the major causes, mechanisms, diagnostic approaches, and management options for secondary hypertension.

Secondary hypertension is defined as high blood pressure that arises from an identifiable underlying condition. Unlike primary (essential) hypertension, which accounts for 90-95% of cases and has no specific cause, secondary hypertension is often linked to medical conditions or certain medications. Identifying and treating the underlying cause is crucial for managing blood pressure effectively. This article delves into the causes, diagnosis, and management of secondary hypertension, focusing on kidney disease, endocrine disorders, sleep apnea, and medication-induced hypertension.

1. Kidney Disease and Hypertension

Chronic Kidney Disease (CKD)

The kidneys are essential for blood pressure regulation via fluid balance and the renin-angiotensin-aldosterone system (RAAS). In chronic kidney disease, the damaged kidneys cannot excrete sodium efficiently, leading to sodium retention, increased blood volume, and subsequent hypertension. Additionally, renal ischemia often stimulates excessive renin release, further exacerbating the condition through vasoconstriction.

Diagnosis:
- Blood tests: Elevated serum creatinine and blood urea nitrogen (BUN) are indicative of impaired kidney function.
- Urinalysis: Proteinuria signals ongoing kidney damage.
- Renal ultrasound: Can reveal shrunken kidneys or structural abnormalities.
- Renin-angiotensin system testing: Measuring plasma renin activity (PRA) and aldosterone levels helps assess RAAS involvement.
Management:
- ACE inhibitors or ARBs: Preferred agents due to their reno-protective properties and efficacy in lowering blood pressure.
- Dialysis or transplant: Required in advanced stages of CKD when kidney function deteriorates significantly.

Renovascular Hypertension (Renal Artery Stenosis)

Renovascular disease, typically caused by atherosclerosis or fibromuscular dysplasia, results in narrowing of the renal arteries, which reduces renal perfusion. The kidney responds by releasing renin, triggering the RAAS and leading to systemic vasoconstriction and sodium retention, which raises blood pressure.

Diagnosis:
- Renal Doppler ultrasound: Non-invasive method to assess blood flow and detect stenosis.
- CT or MR angiography: Provides detailed imaging of the renal arteries to confirm stenosis.
- Captopril renal scan: Helps differentiate renovascular hypertension by assessing kidney function pre- and post-captopril administration, which blocks RAAS.
Management:
- Revascularization: Angioplasty or stenting can restore blood flow to the kidney, improving both renal function and blood pressure control.
- ACE inhibitors or ARBs: Effective in managing renovascular hypertension, but caution is required in bilateral stenosis due to the risk of worsening kidney function.

2. Endocrine Causes of Secondary Hypertension

Primary Hyperaldosteronism (Conn’s Syndrome)

Excess aldosterone production, typically due to an adrenal adenoma or bilateral adrenal hyperplasia, leads to increased sodium reabsorption and potassium excretion. The resulting fluid retention increases blood pressure, while hypokalemia is a classic feature of this condition.

Key diagnostic values:
- Plasma Aldosterone Concentration (PAC): Elevated (>15-20 ng/dL).
- Plasma Renin Activity (PRA): Suppressed (<1 ng/mL/hr).
- Aldosterone-Renin Ratio (ARR): High (>20-30), indicating primary hyperaldosteronism.
Confirmatory tests:
- Saline infusion test or oral sodium loading test: Used to confirm inappropriate aldosterone secretion.
- Imaging: Adrenal CT or MRI to identify adenomas.
Management:
- Surgery: Adrenalectomy is the treatment of choice for unilateral adrenal adenoma.
- Medical therapy: Mineralocorticoid receptor antagonists (e.g., spironolactone) are used for bilateral adrenal hyperplasia or when surgery is not feasible.

Cushing’s Syndrome

Cushing’s syndrome results from prolonged exposure to high levels of cortisol, either from endogenous overproduction or exogenous corticosteroids. Excess cortisol increases blood pressure by enhancing the body's sensitivity to catecholamines and suppressing vasodilatory mechanisms.

Diagnosis:
- 24-hour urinary free cortisol: Elevated cortisol levels confirm the diagnosis.
- Low-dose dexamethasone suppression test: Failure to suppress cortisol levels is diagnostic.
- ACTH levels: Differentiate between ACTH-dependent and ACTH-independent causes.
Management:
- Surgical resection: Adrenalectomy or transsphenoidal surgery (for pituitary adenomas) is the primary treatment.
- Medical management: Cortisol-lowering agents (e.g., ketoconazole, metyrapone) may be used in non-surgical cases.

Pheochromocytoma

Pheochromocytomas are catecholamine-secreting tumors (usually of the adrenal medulla) that cause episodic hypertension. Patients often experience paroxysms of headaches, palpitations, and diaphoresis.

Diagnosis:
- Plasma free metanephrines or urinary fractionated metanephrines: Highly sensitive tests for detecting excess catecholamines.
- Clonidine suppression test: Used to differentiate true pheochromocytoma from other causes of elevated catecholamines.
- Imaging: CT or MRI to locate the tumor.
Management:
- Surgical resection: The definitive treatment.
- Preoperative management: Alpha-blockers (e.g., phenoxybenzamine) are required to control blood pressure before surgery. Beta-blockers are introduced only after adequate alpha blockade to avoid hypertensive crises.

3. Obstructive Sleep Apnea (OSA) and Hypertension

Obstructive sleep apnea is a significant cause of secondary hypertension. During apneic episodes, the body experiences intermittent hypoxia, leading to sympathetic nervous system activation, which raises blood pressure.

Diagnosis:
- Polysomnography (sleep study): Measures the frequency of apneic events and associated oxygen desaturation.
Management:
- Continuous Positive Airway Pressure (CPAP): The first-line treatment for OSA, which helps lower blood pressure by preventing apneic episodes.
- Weight loss: Improves both OSA and blood pressure control.
- Medications: Standard antihypertensives may be required in conjunction with OSA treatment.

4. Medication-Induced Hypertension

Several medications can cause secondary hypertension. It is essential to identify these medications and adjust the treatment accordingly.

Common Offending Medications:

NSAIDs: Lead to sodium retention and decreased renal function, increasing blood pressure.
Oral contraceptives: Estrogens in birth control pills can increase RAAS activity, raising blood pressure.
Corticosteroids: Can lead to sodium and water retention, contributing to hypertension.
Decongestants (e.g., pseudoephedrine): Act as vasoconstrictors, causing transient increases in blood pressure.
Management:
- Medication review: Discontinuation or substitution of the offending medication is crucial.
- Blood pressure control: Antihypertensive agents such as ACE inhibitors or calcium channel blockers can be used while alternative treatments for the primary condition are sought.

Diagnostic Workup in Secondary Hypertension

A detailed history, physical examination, and targeted laboratory and imaging studies are essential in identifying the underlying cause of secondary hypertension. Here are the steps to consider:

Initial Screening:
- Basic laboratory tests: Complete blood count (CBC), metabolic panel (to assess kidney function), and urinalysis (for proteinuria).
- Electrolytes: Hypokalemia is suggestive of hyperaldosteronism.
- Thyroid function tests: To rule out thyroid disease as a cause of hypertension.
- Plasma aldosterone and renin levels: For diagnosing hyperaldosteronism.
Advanced Testing Based on Suspected Cause:
- Renal Doppler or angiography: To assess for renovascular disease.
- 24-hour urine collection: For cortisol in suspected Cushing’s syndrome or metanephrines for pheochromocytoma.
- Polysomnography: In patients with symptoms of sleep apnea.

Conclusion

Secondary hypertension is a potentially reversible form of hypertension that arises due to an identifiable cause. Recognizing its clinical signs, conducting targeted investigations, and implementing specific treatments based on the underlying etiology can lead to better management and outcomes. While the detailed workup may seem complex, an understanding of the mechanisms driving the elevated blood pressure in each condition will guide appropriate diagnostic and therapeutic approaches. Cardiologists and internal medicine practitioners should maintain a high index of suspicion for secondary causes, particularly in patients with resistant hypertension, atypical presentation, or early onset of high blood pressure.